JewishStatusOpen the app

Tachlis Daily Status · Nov 17, 2026

Tachlis Daily Status — photo status

💊 FDA Approves At-Home IGALMI Use for Acute Agitation in Adults With Schizophrenia or Bipolar Disorder Teva says the FDA has approved prescribed at-home use of IGALMI for sudden agitation associated with certain psychiatric conditions in adults. The medicine has safety risks and must be used as prescribed. Teva will announce commercial launch plans later. The photo is an illustrative Canadian facility, not the announcement location. Read more: ✨ #1 Source for Tachlis! News. Media. Music. Simchas. 💙 JOIN OUR GROUP

💊 *FDA Approves At-Home IGALMI Use for Acute Agitation in Adults With Schizophrenia or Bipolar Disorder* Teva says the FDA has approved prescribed at-home use of IGALMI for sudden agitation associated with certain psychiatric conditions in adults. The medicine has safety risks and must be used as prescribed. Teva will announce commercial launch plans later. The photo is an illustrative Canadian facility, not the announcement location. *Read more:* https://tachlisdaily.com/news/fda-approves-at-home-igalmi-use-for-acute-agitation-in-adults-with-schizophrenia ✨ *_#1 Source for Tachlis! News. Media. Music. Simchas._* 💙 *JOIN OUR GROUP* https://chat.whatsapp.com/J7E8c7ly0Sg5MHXub9V4bz

Watch in the app All of Tachlis Daily Status's statuses

More from Tachlis Daily Status